Tax-withholding of 551 shares by Inspire Medical (INSP) officer Jason P. Kelly

Rhea-AI Filing Summary

Inspire Medical Systems, Inc. officer Jason P. Kelly reported a tax-related share disposition. On February 13, 2026, 551 shares of common stock were withheld by the company at $59.76 per share to satisfy taxes upon vesting of a restricted stock unit award. After this withholding, Kelly directly holds 3,990 shares of Inspire Medical Systems common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kelly Jason P

(Last) (First) (Middle)

C/O INSPIRE MEDICAL SYSTEMS, INC.

5500 WAYZATA BLVD., SUITE 1600

(Street)

GOLDEN VALLEY MN 55416

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Inspire Medical Systems, Inc. [ INSP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

3. Date of Earliest Transaction (Month/Day/Year)
02/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/13/2026		F		551(1)	D	$59.76	3,990	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a restricted stock unit award.

Remarks:

Title - Chief Manufacturing and Quality Officer. Exhibit 24 - Power of Attorney.

	/s/ Bryan Phillips, Attorney-in-Fact for Jason P. Kelly	02/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Inspire Medical Systems (INSP) report for Jason P. Kelly?

Inspire Medical Systems reported that officer Jason P. Kelly had 551 common shares withheld to cover taxes on a restricted stock unit vesting. This tax-withholding disposition reduced his position but did not involve an open-market purchase or sale.

How many Inspire Medical Systems shares were involved in Jason P. Kelly’s Form 4 filing?

The Form 4 shows 551 shares of Inspire Medical Systems common stock were disposed of through withholding. These shares were retained by the company to satisfy tax obligations tied to a restricted stock unit award vesting event.

At what price were Jason P. Kelly’s withheld Inspire Medical Systems (INSP) shares valued?

The withheld 551 shares were valued at $59.76 per share. This price is used solely for the tax-withholding disposition related to the restricted stock unit award vesting, rather than reflecting an open-market trading transaction.

How many Inspire Medical Systems (INSP) shares does Jason P. Kelly own after this transaction?

Following the tax-withholding disposition, Jason P. Kelly directly owns 3,990 shares of Inspire Medical Systems common stock. This figure represents his remaining direct holdings after 551 shares were withheld to cover associated tax obligations.

Was Jason P. Kelly’s Inspire Medical Systems Form 4 transaction an open-market sale?

No, the transaction was not an open-market sale. The 551 shares were withheld by Inspire Medical Systems to satisfy taxes from a restricted stock unit vesting, categorized as a tax-withholding disposition rather than a discretionary market trade.